Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Go back to Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026
(NASDAQ: ALLO) Delayed: 1.90 +0.02 (1.06%)
Previous Close $1.88    52 Week High
Open $1.88    52 Week Low
Day High $1.94    P/E N/A 
Day Low $1.86    EPS
Volume 8,642,460